Showing results (2201-2210 of 3,879) with videos related to
Sort By:
Pageof 388
Schizophrenia Research|September 1, 1991
Specificity of smooth pursuit eye movement and visual fixation abnormalities in schizophrenia. Comparison to mania and normal controlsX F Amador, H A Sackeim, S Mukherjee, et al.Fertility and Sterility|April 27, 2010
Twin tubal pregnancy: a rising complication?Ran Svirsky, Ron Maymon, Zvi Vaknin, et al.Journal of the American Society of Nephrology : JASN|February 1, 1991
Glue-sniffing and distal renal tubular acidosis: sticking to the factsE J Carlisle, S M Donnelly, S Vasuvattakul, et al.Work (Reading, Mass.)|January 18, 2013
Development of an instrument to measure the use of behaviors taught in the American Physical Therapy Association Clinical Instructor Education and Credentialing Program (APTA CIECP): a pilot studyPatricia H Bridges, Vincent Carter, Stephanie Rehm, et al.Emotion (Washington, D.C.)|May 31, 2012
Promoting intergroup contact by changing beliefs: group malleability, intergroup anxiety, and contact motivationEran Halperin, Richard J Crisp, Shenel Husnu, et al.European Journal of Neurology|January 3, 2013
Cost-effectiveness of onabotulinumtoxinA for the treatment of wrist and hand disability due to upper-limb post-stroke spasticity in ScotlandQ V Doan, P Gillard, A Brashear, et al.Neurology|April 10, 2013
Evidence-based guideline: treatment of parenchymal neurocysticercosis [RETIRED]: report of the Guideline Development Subcommittee of the American Academy of NeurologyRuth Ann Baird, Sam Wiebe, Joseph R Zunt, et al.Circulation. Arrhythmia and Electrophysiology|November 8, 2014
Interaction between digoxin and dronedarone in the PALLAS trialStefan H Hohnloser, Jonathan L Halperin, A John Camm, et al.Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association|June 1, 1988
Occupational vitiligo due to unsuspected presence of phenolic antioxidant byproducts in commercial bulk rubberM A O'Malley, C G Mathias, M Priddy, et al.Lymphokine and Cytokine Research|December 1, 1991
The specific IL-1 inhibitor from the human M20 cell line is distinct from the IL-1 receptor antagonistV Barak, D Peritt, I Flechner, et al.Pageof 388